Dec 012023
Drug Name |
Active Ingredient(s) |
Approval Date |
FDA-Approved Use on Approval Date |
Press Release |
Drug Trials Snapshot |
| Ogsiveo | nirogacestat | 11/27/2023 | To treat adults with progressing desmoid tumors who require systemic treatment | Drug Trials Snapshot | |
| Truqap | capivasertib | 11/16/2023 | To treat breast cancer that meets certain disease criteria | ||
| Ryzneuta | efbemalenograstim alfa-vuxw | 11/16/2023 | To treat neutropenia | Drug Trials Snapshot | |
| Augtyro | repotrectinib | 11/15/2023 | To treat ROS1-positive non-small cell lung cancer | Drug Trials Snapshot | |
| Defencath | taurolidine, heparin | 11/15/2023 | To reduce the incidence of catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter | Drug Trials Snapshot | |
| Fruzaqla | fruquintinib | 11/8/2023 | To treat refractory, metastatic colorectal cancer | Drug Trials Snapshot |
Sorry, the comment form is closed at this time.